Seroma suppression using TissuGlu® in a high-risk patient post-mastectomy: a case report by Christian Eichler et al.
JOURNAL OF MEDICAL
CASE REPORTS
Eichler et al. Journal of Medical Case Reports 2013, 7:138
http://www.jmedicalcasereports.com/content/7/1/138CASE REPORT Open AccessSeroma suppression using TissuGlu® in a high-risk
patient post-mastectomy: a case report
Christian Eichler1,4*, Faten Dahdouh4, Axel Sauerwald2 and Mathias Warm3Abstract
Introduction: Post-mastectomy seromas are a common problem in modern oncological surgery. Occurrence rates
of up to 59% have been reported in the literature. High-risk patients, that is, those who have received previous
surgeries, radiation or chemotherapy, present a particular challenge. Several surgical techniques, including
progressive tension suture application, have shown promise. Noninvasive measures such as fibrin-based adhesives
have thus far not been able to prevent seroma occurrence effectively. A recent study using a lysine-derived
urethane adhesive named TissuGlu®, however, showed promising results in patients after abdominoplasty.
Case presentation: We used TissuGlu® to treat a high-risk 64-year-old female patient with a history of breast
cancer and severe post-mastectomy seroma. The postsurgical period showed successful seroma suppression,
without any adverse effects or complications.
Conclusions: This type of adhesive should be evaluated as an alternative, less-invasive option for preventing
seroma in patients after a mastectomy.Introduction
Post-mastectomy seromas are a common problem in
modern-day oncological surgery. Complication rates of
up to 59% [1] have been reported in the literature.
Patients who have breast cancer are a high-risk group,
having often undergone previous surgeries, radiation
treatment or chemotherapy. Other risk factors include
smoking habits, increased age and obesity. Patients with
seromas experience effects caused by fluid buildup, such
as prolonged wound healing, increased susceptibility to
infection, necrosis, persistent pain and an overall decrease
in postsurgical quality of life.
A plethora of approaches have been evaluated to reduce
the incidence of seroma formation but, apart from placing
drains, no fundamental progress has been made [2-4]. A
few studies have shown promise in reducing seroma
formation. Two options include the use of progressive
tension suture techniques and the less invasive application
of a lysine-derived urethane adhesive (TissuGlu®, Cohera
Medical, Pittsburgh, PA, USA) [1,5]. We demonstrate the* Correspondence: ceichler@gmail.com
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reproduction in any medium, provided the oruse of TissueGlu® in the successful suppression of post-
mastectomy seromas.Case presentation
We chose to evaluate TissueGlu® in a high-risk situation.
Our patient was a 64-year-old Caucasian woman with a
history of breast cancer. After she was diagnosed with
an invasive ductal carcinoma in her left breast in 1988,
breast-conserving surgery was initially attempted along
with axillary lymph node dissection. Radiation and anti-
hormone therapy followed. After recurrence, our patient
had a mastectomy in 1992 (four years after the original
surgery).
In 2012 (20 years post mastectomy), our patient had
her first revision surgery after local thoracic wall recur-
rence. Standard postsurgical protocols for drain removal
were followed and her wound healing was adequate.
Follow-up visits, however, showed that our patient had
severe seroma formation, requiring weekly drainage of
more than 500mL of fluid. The decision was made to
re-revise and apply TissueGlu®.
Prior to surgery, the procedure was explained and our
patient gave her consent. The surgical procedures did
not differ from routine procedures. Drain placement and
type also did not change. After preparing the surgicalLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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following manufacturer guidelines. A manufacturer ad-
visor was also present to observe the correct application
of the product using the custom drop applicator, which
allowed for equidistant adhesive droplet positioning.
Two drains were placed and wound closure was conti-
nued according to the regular surgical mastectomy stan-
dard. Sterile dressings were then applied, followed by
semi-elastic bandaging of the mastectomy region. Post-
surgical care did not differ from that given to other
patients after a mastectomy. Drain removal was possible
on the fourth (Drain II, total 135mL) and fifth (Drain I,
total 200mL) postsurgical days. Our patient was dis-
charged on the sixth day.
Two-week and four-week follow-up visits showed that
our patient had adequate wound healing without signs
of a seroma. No adverse reaction to the adhesive or
other complications regarding the postsurgical period
were documented.
Discussion
Recent studies have shown that postsurgical fluid accu-
mulation, that is, seroma buildup, may be prevented
using a surgical adhesive within the surgical area itself.
Drain placement, alternative surgical techniques such as
progressive tension or quilting suture techniques, and
mastectomy flap fixation have also shown promise [3,6].
The studies on these techniques are small in patient
numbers and require thorough and extensive analysis in
the future. Some larger studies showed adequate results in
abdominoplasty when using progressive tension suture
techniques; however, applicability to patients undergoing
mastectomies has thus far not been shown [7].
Areas that have received many previous surgeries,
radiation therapy or chemotherapy are rarely positively
influenced by additional sutures. Thus, we attempted to
evaluate a nontraumatic procedure used successfully in
abdominoplasty in a patient with a mastectomy, even
though other types of adhesive have produced poor
results [8-11].
After surgically treating a local thoracic wall recurrence,
postsurgical seroma production required re-revision sur-
gery. This surgery would generally include debridement, if
required, and freshening of the internal wound surface as
well as possible drain placement. We believed that a high-
risk patient, having received several previous surgeries as
well as radiation therapy, would benefit from a nontrau-
matic attempt of preventing further seroma production
through the use of TissuGlu®.
Thus far, no postoperative or intraoperative adverse
reactions have been documented, and we therefore
consider the product safe for use. Adapting the surgical
protocol to allow time for adhesive placement (approxi-
mately three minutes) and cooperating with the manu-facturer allowed an easy transfer of this approach from
abdominoplasty to a post-mastectomy revision situation.
Because no seroma formation was documented in the
postsurgical period, the application of TissueGlu® was
deemed successful. This product may therefore provide
a simple solution to the problem of postsurgical seroma
formation in patients who have had a mastectomy.
Overall, the increase in surgical time of about three
minutes would currently be the only downside in incor-
porating this product into our standard mastectomy
protocol. Using TissueGlu® in a simple revision situation,
as an alternative to drain or suture placement, is also an
option [12].
Naturally, additional costs will be caused by incorpora-
ting TissueGlu® into a surgical protocol. Future studies
should evaluate whether these will be offset by the poten-
tial cost of additional revision surgeries and increased
number of postsurgical follow-ups often required in pa-
tients with a seroma.Conclusions
We attempted to mirror a procedure proven to reduce
postsurgical seroma formation in abdominoplasty in a
patient with a post-mastectomy seroma. No adverse
reaction to the adhesive was documented, seroma for-
mation was not seen and no other complications were
observed. TissuGlu® seems to be a viable option for
seroma suppression in patients with a mastectomy.Consent
Written informed consent was obtained from the patient
for publication of this manuscript. A copy of the written
consent is available for review by the Editor-in-Chief of
this journal.
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